Novartis' R&D expenditure as a percent of revenue 2004-2012 (fee-based)

Reading support:
This statistic represents Swiss-based pharmaceutical company Novartis' expenditure on research and development, from 2004 to 2012, as a percent of revenue. In 2008, research and development expenditure accounted for about 17.4 percent of Novartis' total revenue.